Investigating the use of a limited core outcome variable set for the classification of response following methotrexate treatment in juvenile idiopathic arthritis (JIA)

Antzeko izenburuak

• Investigating which variables from the core outcome variables in juvenile idiopathic arthritis (JIA) are the best predictors of classification as a responder to treatment with methotrexate (MTX)
  nork: Hirani, SP, et al.
  Argitaratua: (2008)
• Are parents' views about their child's treatment for juvenile idiopathic arthritis (JIA) related to evaluations of their child's quality of life (QoL)? – SPARKS CHARM study
  nork: Mulligan, K, et al.
  Argitaratua: (2008)
• Mothers’ reports of the difficulties that their children experience in taking methotrexate for Juvenile Idiopathic Arthritis and how these impact on quality of life
  nork: Mulligan, Kathleen, et al.
  Argitaratua: (2013)
• The experience of taking methotrexate for juvenile idiopathic arthritis: results of a cross-sectional survey with children and young people
  nork: Mulligan, Kathleen, et al.
  Argitaratua: (2015)
• Methotrexate for the treatment of juvenile idiopathic arthritis: process to approval for JIA indication in Japan
  nork: Mori, Masaaki, et al.
  Argitaratua: (2008)